EHA 2015 | Future perspectives in the treatment of acute lymphoblastic leukemia

Dieter Hoelzer

At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, Frankfurt, Germany, discusses the possibilities of immunotherapy for the treatment of patients with acute lymphoblastic leukemia.

Share this video  
Related videos
3:21
Patient-reported outcomes with CAR T-cell therapy
Surbhi Sidana
1:41
Key EHA data, and what to watch for at ASH
Ulrich Jäger
2:23
Nelarabine for R/R T-cell ALL
Robin Foà
2:48
Dasatinib-blinatumomab for ALL
Robin Foà
3:44
Bispecific antibodies in B-ALL; blinatumomab
Robin Foà
Acute Lymphoblastic Leukemia
EHA 2015
12th June 2015
More from Dieter Hoelzer
MRD negativity in ALL
The evolving landscape of ALL therapy and the impact of MRD
CAR T-cells and BiTEs for hematological malignancies
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals